Articles de recherche

Découvrez nos prochaines rencontres scientifiques et activités éducatives axées sur la promotion de la collaboration, le partage de nouvelles données probantes et le renforcement des meilleures pratiques dans le traitement des patients atteints de troubles cardiovasculaires liés au cancer.

Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway.

Auteurs :

Groarke JD, Choueiri TK, Slosky D, Cheng S, Moslehi J.

Publication :

Current Treatment Options Cardiovascular Medicine

Date :

2014 Sep

Pharmacokinetics, Antitumor and Cardioprotective Effects of Liposome-Encapsulated Phenylaminoethyl Selenide in Human Prostate Cancer Rodent Models.

Auteurs :

Kang JY, Eggert M, Mouli S, Aljuffali I, Fu X, Nie B, Sheil A, Waddey K, Oldham CD, May SW, Amin R, Arnold RD.

Publication :

Pharmaceutical Research

Date :

2014 Aug 27

Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).

Auteurs :

Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, Kremer LC, Lenihan DJ, Sallan SE, Sawyer DB, Suter TM, Swain SM, van Leeuwen FE.

Publication :

Ecancermedicalscience

Date :

2014 May 29

Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: A review of the protective role of melatonin.

Auteurs :

Govender J, Loos B, Marais E, Engelbrecht AM.

Publication :

Journal of Pineal Res

Date :

2014 Sep 17

Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study.

Auteurs :

Kobashigawa LC, Xu YC, Padbury JF, Tseng YT, Yano N.

Publication :

PLoS One

Date :

2014 Aug 15

Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.

Auteurs :

Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF.

Publication :

Cardiology in the Young

Date :

2014 Oct

Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.

Auteurs :

Nasr M, Nafee N, Saad H, Kazem A.

Publication :

European Journal of Pharmaceutics and Biopharmaceutics

Date :

2014 Sep

Ottawa Cardiac Oncology Program wins 2013 Cancer Quality Council of Ontario Innovation Award.

Auteurs :

Sulpher J, Johnson C, Turek M, Law A, Stadnick E, Hopkins S, Graham N, Dent SF.

Publication :

Current Oncology

Date :

2014 Jun

Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis.

Auteurs :

Xiao Y, Yin J, Wei J, Shang Z.

Publication :

PLoS One

Date :

2014 Jan 29

Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Auteurs :

Lipshultz SE, Diamond MB, Franco VI, Aggarwal S, Leger K, Santos MV, Sallan SE, Chow EJ.

Publication :

Paediatric Drugs

Date :

2014 Oct